Pacific Edge shares at 13-year high, halted for NZX share price inquiry

Pacific Edge shares at 13-year high, halted for NZX share price inquiry
Sept. 21 (BusinessDesk) - Pacific Edge, the Dunedin-based DNA diagnostic test company, had its shares halted by NZX Market Supervision after they jumped to a 13-year high. The shares rose 13 percent to 34 cents today, the highest since they spiked to 46 cents on May 9, 2004, and have gained 47 percent this year. That values the company at $93 million. Share price inquiries typically ask if a company is privy to any information not generally known in the market that could account for an unusual move in its shares. The last statement from the...